[MYGN] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
09-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 207.14%
YoY- -44.87%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 93,200 215,400 200,900 200,500 186,500 189,900 188,765 -11.08%
PBT -58,500 -7,700 16,100 18,800 37,300 35,500 52,550 -
Tax -3,000 -3,400 3,000 6,100 13,900 16,800 18,921 -
NP -55,400 -4,200 13,100 12,900 23,400 18,700 33,629 -
Tax Rate - - -18.63% -32.45% -37.27% -47.32% -36.01% -
Total Cost 148,600 219,600 187,800 187,600 163,100 171,200 155,136 -0.71%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -59.44 -1.95 6.52 6.43 12.55 9.85 17.82 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -0.74 -0.06 0.19 0.19 0.33 0.27 0.45 -
EPS Diluted -0.74 -0.06 0.18 0.19 0.32 0.26 0.43 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.